Pluri Inc. Gain (Loss) on Derivative Instruments, Net, Pretax
Pluri Inc. (PLUR) reported Gain (Loss) on Derivative Instruments, Net, Pretax of -$105.00 thousand for the 12-month period ending 2019-06-30, per its 10-K filed 2019-09-12.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2019-09-12
- Pluri Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2015-06-30 was $436.00K, a 14433.33% increase year-over-year.
- Pluri Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2015-03-31 was $98.00K.
- Pluri Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2014-12-31 was $59.00K.
- Pluri Inc. gain (loss) on derivative instruments, net, pretax for the quarter ending 2014-09-30 was -$198.00K.
- Pluri Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2019 was -$105.00K.
- Pluri Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2018 was -$264.00K, a 154.89% decline from fiscal 2017.
- Pluri Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2017 was $481.00K.
- Pluri Inc. gain (loss) on derivative instruments, net, pretax for fiscal 2016 was -$30.00K, a 107.59% decline from fiscal 2015.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month as first filed |
|---|---|---|---|---|---|
| 2019-06-30 | -$105.00K 10-K · filed 2019-09-12 | ||||
| 2018-06-30 | -$264.00K 10-K · filed 2019-09-12 | ||||
| 2017-06-30 | $481.00K 10-K · filed 2019-09-12 | ||||
| 2016-06-30 | -$30.00K 10-K · filed 2018-09-12 | ||||
| 2015-06-30 | $436.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $534.00K derived: sum of 2 quarters · filed 2017-09-07 | $593.00K derived: sum of 3 quarters · filed 2017-09-07 | $395.00K 10-K · filed 2017-09-07 | |
| 2015-03-31 | $98.00K 10-Q · filed 2015-05-06 | $157.00K derived: sum of 2 quarters · filed 2015-05-06 | -$41.00K 10-Q · filed 2015-05-06 | -$38.00K derived: sum of 4 quarters · filed 2016-09-07 | |
| 2014-12-31 | $59.00K 10-Q · filed 2015-02-05 | -$139.00K 10-Q · filed 2015-02-05 | -$136.00K derived: sum of 3 quarters · filed 2016-09-07 | -$165.00K derived: sum of 4 quarters · filed 2016-09-07 | |
| 2014-09-30 | -$198.00K 10-Q · filed 2014-11-06 | -$195.00K derived: sum of 2 quarters · filed 2016-09-07 | -$224.00K derived: sum of 3 quarters · filed 2016-09-07 | -$281.00K derived: sum of 4 quarters · filed 2016-09-07 | |
| 2014-06-30 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | -$26.00K derived: sum of 2 quarters · filed 2016-09-07 | -$83.00K derived: sum of 3 quarters · filed 2016-09-07 | -$83.00K 10-K · filed 2016-09-07 | -$70.00K 10-K · filed 2014-09-11 |
| 2014-03-31 | -$29.00K 10-Q · filed 2015-05-06 | -$86.00K derived: sum of 2 quarters · filed 2015-05-06 | -$86.00K 10-Q · filed 2015-05-06 | ||
| 2013-12-31 | -$57.00K 10-Q · filed 2015-02-05 | -$50.00K 10-Q · filed 2015-02-05 | |||
| 2013-09-30 | -$7.00K 10-Q · filed 2014-11-06 | ||||
| 2013-06-30 | $140.00K 10-K · filed 2015-09-09 | $231.00K 10-K · filed 2014-09-11 | |||
| 2012-06-30 | -$145.00K 10-K · filed 2014-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |